JAMA Clinical Reviews cover image

Treatment of Keratinocyte Carcinoma

JAMA Clinical Reviews

00:00

Recurrence Risk and New Lesion Likelihood

David asks for numbers; Dr. Wehner reports low recurrence rates after treatment but about 40% risk of a new keratinocyte carcinoma within five years.

Play episode from 17:17
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app